{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T01:45:56Z","timestamp":1782956756418,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":58,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pars plana vitrectomy (PPV) in young type 1 diabetes mellitus (T1DM) patients presents greater surgical challenges than in type 2 (T2DM) cases. Despite advances in vitreoretinal surgery, there is no universally accepted classification system for tractional retinal detachment (TRD), and limited data exist on the comparative effectiveness of endotamponade agents and the prognostic significance of outer retinal biomarkers in T1DM cohorts. This study evaluates PPV outcomes for TRD and combined tractional rhegmatogenous retinal detachment (TRRD) in T1DM, introduces a proposed staging system for TRD, assesses the impact of tamponade selection on outcomes, and investigates the role of outer retinal structural biomarkers in predicting visual success.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort study was conducted at King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia, on T1DM patients treated with PPV for TRD and combined TRRD between June 2014 and December 2022. A novel TRD staging system was proposed based on the extent of the tractional membrane, posterior hyaloid attachment status, and the presence of retinal breaks, classifying cases into simple TRD (stages 1, 2, 3a), complex TRD (stages 3b, 4, 5), and combined TRRD (acute and chronic). Anatomical success was defined as retinal reattachment, and visual success was defined as improvement in visual acuity of more than two Snellen lines. Postoperative optical coherence tomography (OCT) at 1 year assessed external limiting membrane (ELM) and ellipsoid zone (EZ) integrity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 339 eyes (255 patients), complex TRD was the most common presentation (41.6%). Iatrogenic retinal breaks occurred in 39.2%, and tamponade was used in 74.0% of cases. Anatomical success was achieved in 73.2% after a single surgery and 91.2% overall. Visual success was achieved in 55.2% of eyes, with vision improvement observed in 69.2%. Eyes without tamponade achieved the highest visual success rate (80.8%), followed by gas tamponade (84.3% for C3F8\/SF6) compared to silicone oil (51.9%) (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Combined TRRD had significantly lower visual success compared to complex TRD (47.3% vs. 64.5%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.018). Multivariate analysis identified preoperative LogMAR visual acuity (RR 9.88, 95% CI: 4.68\u201320.83,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), intact ellipsoid zone status (RR 20.4, 95% CI: 3.8\u2013109.41,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), combined TRRD stage (RR 0.08, 95% CI: 0.01\u20130.5,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.007), and absence of subretinal fluid (RR 3.49, 95% CI: 1.12\u201310.87,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.031) as significant independent predictors of visual success.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PPV for TRD in T1DM achieves excellent overall anatomical outcomes. The proposed TRD staging system demonstrated prognostic value, with combined TRRD carrying a worse visual prognosis. Preoperative visual acuity, TRD stage, outer retinal integrity (ELM\/EZ) on postoperative OCT, and tamponade type were significant determinants of functional outcomes. The association of silicone oil tamponade with poorer visual outcomes likely reflects indication bias, as silicone oil was preferentially used in more complex cases. The proposed staging system is hypothesis-generating and requires prospective multicenter validation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40942-026-00835-0","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T05:45:08Z","timestamp":1777959908000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pars plana vitrectomy for tractional and combined tractional rhegmatogenous retinal detachment in type 1 diabetes mellitus: outcomes, prognostic factors, and a proposed staging system"],"prefix":"10.1186","volume":"12","author":[{"given":"Mohammed S.","family":"Alshehri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adhwa","family":"Alsadoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alanaud","family":"Albazei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turki","family":"Algethami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Mura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulaiman M.","family":"Alsulaiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal S.","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"key":"835_CR1","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","volume":"376","author":"N Cheung","year":"2010","unstructured":"Cheung N, Mitchell P, Wong T. Y. 1.Diabetic retinopathy. Lancet. 2010;376:124\u201336.","journal-title":"Lancet"},{"key":"835_CR2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","volume":"402","author":"KL Ong","year":"2023","unstructured":"Ong KL, et al. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402:203\u201334.","journal-title":"Lancet"},{"key":"835_CR3","doi-asserted-by":"publisher","first-page":"428","DOI":"10.4103\/0301-4738.100542","volume":"60","author":"Y Zheng","year":"2012","unstructured":"Zheng Y, He M, Congdon N. The worldwide epidemic of diabetic retinopathy. Indian J Ophthalmol. 2012;60:428\u201331.","journal-title":"Indian J Ophthalmol"},{"key":"835_CR4","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/S0161-6420(92)31779-8","volume":"99","author":"HW Flynn","year":"1992","unstructured":"Flynn HW, et al. 11.Pars plana vitrectomy in the Early Treatment Diabetic Retinopathy Study. ETDRS report number 17. The Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1992;99:1351\u20137.","journal-title":"Ophthalmology"},{"key":"835_CR5","unstructured":"Diabetic retinopathy vitrectomy study (DRVS). Landmark Trials - Eyedocs. https:\/\/www.eyedocs.co.uk\/ophthalmology-journal-articles-classic\/1101-diabetic-retinopathy-vitrectomy-study-drvs.html."},{"key":"835_CR6","doi-asserted-by":"crossref","unstructured":"Liao M, et al. Characteristics and outcomes of vitrectomy for proliferative diabetic retinopathy in young versus senior patients. BMC Ophthalmol 2020;20.","DOI":"10.1186\/s12886-020-01688-3"},{"key":"835_CR7","doi-asserted-by":"crossref","unstructured":"Ka\u017amierczak K, \u017buchowski P, Stafiej J, Malukiewicz G. Functional and structural outcomes and complications after pars plana vitrectomy for severe features of proliferative diabetic retinopathy in type 1 and type 2 diabetes mellitus. PLoS ONE 2023;18.","DOI":"10.1371\/journal.pone.0288805"},{"key":"835_CR8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000098253","volume":"221","author":"P Kroll","year":"2007","unstructured":"Kroll P, B\u00fcchele Rodrigues E, Hoerle S. Pathogenesis and classification of proliferative diabetic vitreoretinopathy. Ophthalmologica. 2007;221:78\u201394.","journal-title":"Ophthalmologica"},{"issue":"1 30","key":"835_CR9","first-page":"34","volume":"30","author":"I Dooley","year":"2015","unstructured":"Dooley I, Laviers H, Papavasileiou E, McKechnie C, Zambarakji H. Spectral domain ocular coherence tomography findings pre- and post vitrectomy with fibrovascular membrane delamination for proliferative diabetic retinopathy. Eye 2016. 2015;30(1 30):34\u20139.","journal-title":"Eye 2016"},{"issue":"3","key":"835_CR10","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1136\/bjo.87.3.318","volume":"87","author":"A Castellarin","year":"2003","unstructured":"Castellarin A, Grigorian R, Bhagat N, Del Priore L, Zarbin MA. Vitrectomy with silicone oil infusion in severe diabetic retinopathy. Br J Ophthalmol. 2003;87(3):318\u201321.","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"835_CR11","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1136\/bjo.87.6.737","volume":"87","author":"RA Grigorian","year":"2003","unstructured":"Grigorian RA, Castellarin A, Fegan R, et al. Epiretinal membrane removal in diabetic eyes: comparison of viscodissection with conventional methods of membrane peeling. Br J Ophthalmol. 2003;87(6):737\u201341.","journal-title":"Br J Ophthalmol"},{"key":"835_CR12","doi-asserted-by":"publisher","first-page":"917375","DOI":"10.1155\/2014\/917375","volume":"2014","author":"YJ Hsu","year":"2014","unstructured":"Hsu YJ, Hsieh YT, Yeh PT, Huang JY, Yang CM. Combined Tractional and Rhegmatogenous Retinal Detachment in Proliferative Diabetic Retinopathy in the Anti-VEGF Era. J Ophthalmol. 2014;2014:917375.","journal-title":"J Ophthalmol"},{"key":"835_CR13","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/aos.12951","volume":"94","author":"ZY Wang","year":"2016","unstructured":"Wang ZY, Zhao KK, Li JK, Rossmiller B, Zhao P. Q. Four-port bimanual 23-gauge vitrectomy for diabetic tractional retinal detachment. Acta Ophthalmol. 2016;94:365\u201372.","journal-title":"Acta Ophthalmol"},{"key":"835_CR14","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1016\/S0161-6420(02)01291-5","volume":"109","author":"RL Steinmetz","year":"2002","unstructured":"Steinmetz RL, Grizzard WS, Hammer ME. Vitrectomy for diabetic traction retinal detachment using the multiport illumination system. Ophthalmology. 2002;109:2303\u20137.","journal-title":"Ophthalmology"},{"key":"835_CR15","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1097\/IAE.0000000000003052","volume":"41","author":"RB Rush","year":"2021","unstructured":"Rush RB, Valle Penella D, Reinauer A, Rush RM, S. W., Bastar PG. Silicone oil versus perfluoropropane gas tamponade during vitrectomy for tractional retinal detachment or fibrous proliferation: a randomized clinical trial. Retina. 2021;41:1407\u201315.","journal-title":"Retina"},{"key":"835_CR16","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/j.1755-3768.2011.02248.x","volume":"90","author":"UC Christensen","year":"2012","unstructured":"Christensen UC, La Cour M. Visual loss after use of intraocular silicone oil associated with thinning of inner retinal layers. Acta Ophthalmol. 2012;90:733\u20137.","journal-title":"Acta Ophthalmol"},{"key":"835_CR17","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/IAE.0b013e3181d374a5","volume":"30","author":"Y Tao","year":"2010","unstructured":"Tao Y, Jiang YR, Li XX, Gao L, Jonas JB. Long-term results of vitrectomy without endotamponade in proliferative diabetic retinopathy with tractional retinal detachment. Retina. 2010;30:447\u201351.","journal-title":"Retina"},{"key":"835_CR18","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1097\/IAE.0000000000001793","volume":"38","author":"PP Storey","year":"2018","unstructured":"Storey PP, et al. Visual and anatomical outcomes after diabetic traction and traction-rhegmatogenous retinal detachment repair. Retina. 2018;38:1913\u20139.","journal-title":"Retina"},{"key":"835_CR19","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1136\/bjo.2007.124495","volume":"92","author":"D Yorston","year":"2008","unstructured":"Yorston D, et al. Predictive clinical features and outcomes of vitrectomy for proliferative diabetic retinopathy. Br J Ophthalmol. 2008;92:365\u20138.","journal-title":"Br J Ophthalmol"},{"key":"835_CR20","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1001\/archopht.1987.01060040067035","volume":"105","author":"T de JT","year":"1987","unstructured":"de JT T B., RG, M., TA R. Results and prognostic factors in vitrectomy for diabetic traction retinal detachment of the macula. Arch Ophthalmol. 1987;105:497\u2013502.","journal-title":"Arch Ophthalmol"},{"key":"835_CR21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/0002-9394(83)90330-6","volume":"95","author":"TA Rice","year":"1983","unstructured":"Rice TA, Michels RG, Rice E. F. Vitrectomy for diabetic traction retinal detachment involving the macula. Am J Ophthalmol. 1983;95:22\u201333.","journal-title":"Am J Ophthalmol"},{"key":"835_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2017.08.013","volume":"183","author":"J Castillo","year":"2017","unstructured":"Castillo J, Aleman I, Rush SW, Rush RB. Preoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy: A Randomized and Controlled Trial Comparing Interval Variation. Am J Ophthalmol. 2017;183:1\u201310.","journal-title":"Am J Ophthalmol"},{"key":"835_CR23","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.4103\/ijo.IJO_1293_21","volume":"69","author":"K Kumar","year":"2021","unstructured":"Kumar K, et al. Clinical features and surgical outcomes of complications of proliferative diabetic retinopathy in young adults with type 1 diabetes mellitus versus type 2 diabetes mellitus - A comparative observational study. Indian J Ophthalmol. 2021;69:3289.","journal-title":"Indian J Ophthalmol"},{"key":"835_CR24","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00417-016-3579-4","volume":"255","author":"CH Huang","year":"2017","unstructured":"Huang CH, Hsieh YT, Yang CM. Vitrectomy for complications of proliferative diabetic retinopathy in young adults: clinical features and surgical outcomes. Graefes Arch Clin Exp Ophthalmol. 2017;255:863\u201371.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"835_CR25","doi-asserted-by":"publisher","unstructured":"Spandau U, Tomic Z. Anatomical pathology of diabetic retinopathy. small-gauge vitrectomy diabet retinopathy. 2023;11\u20136. https:\/\/doi.org\/10.1007\/978-3-031-26204-3_2.","DOI":"10.1007\/978-3-031-26204-3_2"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-026-00835-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-026-00835-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-026-00835-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T01:11:05Z","timestamp":1782954665000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40942-026-00835-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["835"],"URL":"https:\/\/doi.org\/10.1186\/s40942-026-00835-0","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"assertion":[{"value":"14 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Due to the retrospective nature of the study, the requirement for informed consent was waived by the Institutional Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"90"}}